A detailed history of Amalgamated Bank transactions in Twist Bioscience Corp stock. As of the latest transaction made, Amalgamated Bank holds 2,031 shares of TWST stock, worth $84,611. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,031
Previous 2,031 -0.0%
Holding current value
$84,611
Previous $100,000 8.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$27.95 - $53.0 $2,515 - $4,770
90 Added 4.64%
2,031 $100,000
Q1 2024

Apr 23, 2024

SELL
$32.28 - $41.5 $98,324 - $126,409
-3,046 Reduced 61.08%
1,941 $67,000
Q4 2023

Feb 06, 2024

SELL
$15.08 - $38.61 $8,716 - $22,316
-578 Reduced 10.39%
4,987 $184,000
Q2 2023

Aug 11, 2023

SELL
$11.49 - $20.46 $20,969 - $37,339
-1,825 Reduced 24.7%
5,565 $113,000
Q1 2023

May 02, 2023

SELL
$14.6 - $30.9 $15,213 - $32,197
-1,042 Reduced 12.36%
7,390 $111,000
Q3 2022

Nov 09, 2022

BUY
$33.44 - $56.56 $3,277 - $5,542
98 Added 1.18%
8,432 $297,000
Q2 2022

Aug 15, 2022

SELL
$26.2 - $54.0 $8,986 - $18,522
-343 Reduced 3.95%
8,334 $291,000
Q1 2022

Jun 30, 2022

BUY
$38.58 - $83.27 $14,197 - $30,643
368 Added 4.43%
8,677 $428,000
Q4 2021

Feb 15, 2022

SELL
$75.47 - $135.88 $6,792 - $12,229
-90 Reduced 1.07%
8,309 $643,000
Q3 2021

Oct 29, 2021

SELL
$95.64 - $131.48 $49,541 - $68,106
-518 Reduced 5.81%
8,399 $898,000
Q2 2021

Aug 16, 2021

BUY
$88.13 - $142.06 $196,618 - $316,935
2,231 Added 33.37%
8,917 $1.19 Million
Q1 2021

May 13, 2021

BUY
$105.48 - $207.97 $166,025 - $327,344
1,574 Added 30.79%
6,686 $828,000
Q4 2020

Feb 12, 2021

BUY
$76.64 - $167.89 $1,992 - $4,365
26 Added 0.51%
5,112 $722,000
Q3 2020

Oct 30, 2020

BUY
$45.46 - $78.79 $13,819 - $23,952
304 Added 6.36%
5,086 $386,000
Q2 2020

Aug 10, 2020

BUY
$26.4 - $45.3 $126,244 - $216,624
4,782 New
4,782 $217,000

Others Institutions Holding TWST

About Twist Bioscience Corp


  • Ticker TWST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 56,363,500
  • Market Cap $2.35B
  • Description
  • Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...
More about TWST
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.